Search results for "hate"

showing 10 items of 2099 documents

Abnormal pentagastrin response in a patient with pseudohypoparathyroidism

2002

The case of a 25 year old female patient with pseudohypoparathyroidism type I (PHP) and hypercalcitoninaemia is reported. She was referred to our clinic because of recurrent hypocalcaemia associated with paraesthesias and muscle cramps. She had no signs of Albright hereditary osteodystrophy (AHO), a normal mental status and no family history of hypocalcaemia or any other endocrine disease. Considering the laboratory results with hypocalcaemia, hyperphosphataemia, normal vitamin D and normal creatinine with an extraordinary elevated PTH we diagnosed pseudohypoparathyroidism type I. She had delayed pubertal development with menarche in the age of 20 and hypothyroidism with an atrophic thyroid…

AdultCalcitoninmusculoskeletal diseasesmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismGastroenterologyPhosphatesEndocrinologyHypothyroidismInternal medicineInternal MedicinemedicineHumansHypocalcaemiaFamily historyPseudohypoparathyroidismPuberty DelayedEndocrine diseaseHypocalcemiabusiness.industryThyroidGeneral MedicineAlkaline Phosphatasemedicine.diseasePentagastrinmedicine.anatomical_structureEndocrinologyCalcitoninPseudohypoparathyroidismCalciumFemalePentagastrinmedicine.symptombusinessMuscle crampmedicine.drugExperimental and Clinical Endocrinology & Diabetes
researchProduct

Treatment of intrabony defects using guided tissue regeneration and autogenous spongiosa alone or combined with hydroxyapatite/beta-tricalcium phosph…

2007

The aim of this case-control study was to investigate the clinical regeneration of deep intrabony defects using guided tissue regeneration (GTR) with autogenous spongiosa (ASB) alone or using GTR with a mixture of ASB with a bovine-derived xenograft (BDX) or a synthetic composite bone substitute (hydroxyapatite/beta-tricalcium phosphate [HA/beta-TCP]).Sixty-four patients with a total of 93 intrabony defects of 2- or 3-wall morphology and an intrabony component (IC)or=4 mm participated in this study. Defects were treated with a bioabsorbable membrane and ASB alone or ASB mixed with HA/beta-TCP or BDX. Clinical parameters measured at baseline and 12 months after surgery included IC, bleeding …

AdultCalcium PhosphatesMaleBone substituteBleeding on probingTransplantation HeterologousDentistrymedicineAnimalsHumansBone regenerationPeriodontitisAgedPeriodontitisβ tricalcium phosphatebusiness.industryRegeneration (biology)SmokingAlveolar Ridge AugmentationAlveolar Ridge AugmentationMiddle Agedmedicine.diseaseTreatment efficacyBone SubstitutesGuided Tissue Regeneration PeriodontalPeriodonticsCattleFemaleHydroxyapatitesmedicine.symptombusinessEpidemiologic MethodsJournal of periodontology
researchProduct

Volume stability of hydroxyapatite and β-tricalcium phosphate biphasic bone graft material in maxillary sinus floor elevation: a radiographic study u…

2015

Objectives The purpose of this study was to confirm volume stability of biphasic calcium phosphate (BCP) through the changes of grafted volume over the time by 3D CT analyzing software program. Patients and Methods Fifteen patients, 16 sinuses who were scheduled a staged implantation through sinus floor elevation (SFE)–lateral window technique from 2009 to 2011 were included in the study. Of the 15 patients, eight were male and seven were female (mean age 50.1). For sinus floor augmentation, BCP with local blood was packed loosely into the maxillary sinus and the grafted site was covered with a collagen membrane. For the evaluation of volume change, 3D CBCT scans were taken five times at pr…

AdultCalcium PhosphatesMaleCone beam computed tomographySinus Floor Augmentationmedicine.medical_specialtyMaterials scienceMaxillary sinusRadiographySinus Floor AugmentationSinus floor elevation03 medical and health sciencesImaging Three-Dimensional0302 clinical medicinemedicineHumansProspective Studies030212 general & internal medicineAgedβ tricalcium phosphatebusiness.industry3d image processingMembranes Artificial030206 dentistryCone-Beam Computed TomographyMiddle AgedSurgeryDurapatiteTreatment Outcomemedicine.anatomical_structureVolume (thermodynamics)Bone SubstitutesRadiographic Image Interpretation Computer-AssistedFemaleCollagenOral SurgerybusinessBiomedical engineeringClinical Oral Implants Research
researchProduct

The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

2007

Epithelial to mesenchymal transition (EMT) is implicated in the progression of primary tumours towards metastasis and is likely caused by a pathological activation of transcription factors regulating EMT in embryonic development. To analyse EMT-causing pathways in tumouri-genesis, we identified transcriptional targets of the E-cadherin repressor ZEB1 in invasive human cancer cells. We show that ZEB1 repressed multiple key determinants of epithelial differentiation and cell–cell adhesion, including the cell polarity genes Crumbs3, HUGL2 and Pals1-associated tight junction protein. ZEB1 associated with their endogenous promoters in vivo, and strongly repressed promotor activities in reporter …

AdultCancer ResearchChromatin ImmunoprecipitationCellular differentiationImmunoblottingDown-RegulationBreast NeoplasmsBiologymedicine.disease_causeEpitheliumArticleCell polarityGeneticsmedicineTumor Cells CulturedHumansNeoplasm InvasivenessEpithelial–mesenchymal transitionCell adhesionPromoter Regions GeneticMolecular BiologyTranscription factorEpithelial polarityAgedOligonucleotide Array Sequence AnalysisHomeodomain ProteinsMembrane GlycoproteinsReverse Transcriptase Polymerase Chain ReactionGene Expression ProfilingCell PolarityMembrane ProteinsZinc Finger E-box-Binding Homeobox 1Cell DifferentiationMiddle AgedCadherinsCytoskeletal ProteinsMicroscopy FluorescenceCancer cellColonic NeoplasmsCancer researchDisease ProgressionSnail Family Transcription FactorsCarcinogenesisNucleoside-Phosphate KinaseTranscription FactorsOncogene
researchProduct

Development of a novel methodology for determination of dialkyl phosphates in human urine using liquid chromatography-tandem mass spectrometry

2019

Abstract In this study a fast and sensitive method was developed for the quantitative determination of six dialkyl phosphates (DAPs) in human urine using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The proposed methodology was based on liquid-liquid extraction (LLE) with diethyl ether and ethyl acetate using MgSO4 and NaCl, followed by liquid chromatography and mass spectrometry detection in the selected reaction mode (SRM) with negative electrospray ionization (ESI-). Detection settings were optimized by design of experiments (DoE). Dibutyl phosphate (DBP) was used as internal standard. Several criteria established in the SANTE/11813/2017 guidance document for pesticide resi…

AdultElectrospray ionizationClinical BiochemistryEthyl acetateMass spectrometry030226 pharmacology & pharmacy01 natural sciencesBiochemistryPhosphatesAnalytical ChemistryYoung Adult03 medical and health scienceschemistry.chemical_compoundOrganophosphorus Compounds0302 clinical medicineLimit of DetectionTandem Mass SpectrometryLiquid–liquid extractionLiquid chromatography–mass spectrometryHumansLactationChromatography High Pressure LiquidDetection limitChromatography010401 analytical chemistryExtraction (chemistry)Pesticide ResiduesReproducibility of ResultsCell BiologyGeneral Medicine0104 chemical scienceschemistryLinear ModelsFemaleDiethyl etherJournal of Chromatography B
researchProduct

Potential effects of age-associated oxidative stress on mammalian oocytes/embryos

1996

This bioessay aims to explain the different effects of maternal ageing and postovulatory oocyte ageing on mammalian oocytes/embryos under the scope of 'the oxygen radical-mitochondrial injury hypothesis of ageing'. This hypothesis assumes a key role in the senescent process of oxygen radical damage to mitochondrial DNA, proteins and lipids. It is proposed that a decrease in intracellular ATP concentrations and glutathione (GSH)/glutathione disulphide (GSSG) ratio together with a concomitant increase in cytosolic Ca2+ are major factors causing the observed detrimental effects of ageing on cytoskeletal fibres, fertilization and embryo development.

AdultFetal ProteinsEmbryologyBiologymedicine.disease_causeDNA MitochondrialCongenital AbnormalitiesMicechemistry.chemical_compoundAdenosine TriphosphateNeoplasmsGeneticsmedicineAnimalsHumansMolecular BiologyCellular SenescenceCytoskeletonMammalsEgg ProteinsEmbryogenesisObstetrics and GynecologyEmbryoCell BiologyGlutathioneEmbryo MammalianOocyteGlutathioneCell biologyOxidative StressCytosolFertilitymedicine.anatomical_structureReproductive MedicineBiochemistrychemistryAgeingFertilizationOocytesReactive Oxygen SpeciesOxidation-ReductionIntracellularOxidative stressMaternal AgeDevelopmental BiologyMolecular Human Reproduction
researchProduct

Galactose increase in an infant whose mother is heterozygous for peripheral uridine diphosphate galactose‐4‐epimerase deficiency

1991

AdultGalactosemiasMaleHeterozygotemedicine.medical_specialtyUridine diphosphate galactose-4-epimeraseBiologyUDPglucose 4-Epimerasechemistry.chemical_compoundInternal medicineGeneticsmedicineHumansTransaminasesGenetics (clinical)chemistry.chemical_classificationClinical Laboratory TechniquesGalactosemiaInfant NewbornCarbohydratemedicine.diseaseBreast FeedingEndocrinologyEnzymeBiochemistrychemistryRecien nacidoGalactoseFemaleInfant FoodJournal of Inherited Metabolic Disease
researchProduct

Distributions and determinants of urinary biomarkers of organophosphate pesticide exposure in a prospective Spanish birth cohort study

2017

Background: Prenatal exposure to organophosphate pesticides (OPs) has been associated with impaired child development. Pesticide exposure determinants need to be studied in order to identify sources and pathways of pesticide exposure. The aim of this paper is to describe prenatal exposure to OPs and evaluate the associated factors in pregnant women. Methods: The study population consisted of pregnant women ( n = 573) who participated in the INMA birth cohort study in Valencia (Spain, 2003 – 2006). OP metabolites were analyzed in maternal urine at the 32nd week of gestation using a liquid chromatography-high resolution mass spectrometry method. The analysis included non-specific (diethyl pho…

AdultInsecticidesmedicine.medical_specialtyHealth Toxicology and Mutagenesis010501 environmental sciencesDevelopment01 natural sciencesCohort StudiesToxicologylcsh:RC963-96903 medical and health scienceschemistry.chemical_compoundOrganophosphorus Compounds0302 clinical medicinePregnancyEnvironmental healthVegetablesmedicineHumans030212 general & internal medicinePesticides0105 earth and related environmental sciences2. Zero hungerPregnancyFetusbusiness.industrylcsh:Public aspects of medicineResearchPublic healthOrganophosphatePublic Health Environmental and Occupational Healthlcsh:RA1-1270Agriculturemedicine.disease3. Good healthDietTCPychemistryMaternal ExposureSpainFruitlcsh:Industrial medicine. Industrial hygieneGestationPopulation studyEnvironmental PollutantsFemalebusinessBody mass index
researchProduct

Cellular-free magnesium depletion in brain and muscle of normal and preeclamptic pregnancy: A nuclear magnetic resonance spectroscopic study

2004

Preeclampsia is a pregnancy disorder of unknown origin, characterized by vasospasm, elevated blood pressure, and increased neuromuscular irritability, features common to syndromes of magnesium deficiency. Evidence of serum and ionized magnesium metabolism disturbances have been observed in women with preeclampsia. This and the therapeutic utility of magnesium in preeclampsia led us to investigate the extent to which an endogenous tissue magnesium deficiency might be present in and contribute to its pathophysiology. We used 31 P nuclear magnetic resonance spectroscopy to noninvasively measure in situ intracellular-free magnesium levels in brain and skeletal muscle of fasting nonpregnant wom…

AdultIntracellular Fluidmedicine.medical_specialtyPregnancy Trimester ThirdDiastolechemistry.chemical_elementBlood PressurePreeclampsiaAdenosine TriphosphatePre-EclampsiaPregnancyMagnesium deficiency (medicine)Internal medicineInternal MedicinemedicineHumansMagnesiumIonMuscle SkeletalNuclear Magnetic Resonance BiomolecularBrain ChemistryMagnesiumbusiness.industrySkeletal muscleFastingHydrogen-Ion Concentrationmedicine.diseasePreeclampsiaPathophysiologymedicine.anatomical_structureBlood pressureEndocrinologyMetabolismchemistryFemalebusinessMagnesium DeficiencyPregnancy disorder
researchProduct

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractor…

2018

AbstractPurpose:Here, we report results of the first phase I study of erdafitinib, a potent, oral pan-FGFR inhibitor.Patients and Methods:Patients age ≥18 years with advanced solid tumors for which standard antineoplastic therapy was no longer effective were enrolled (NCT01703481). Parts 2 to 4 employed molecular screening for activating FGFR genomic alterations. In patients with such alterations, two selected doses/schedules identified during part 1 dose-escalation [9 mg once daily and 10 mg intermittently (7 days on/7 days off), as previously published (Tabernero JCO 2015;33:3401-8)] were tested.Results:The study included 187 patients. The most common treatment-related adverse events were…

AdultMale0301 basic medicineCancer Researchmedicine.medical_specialtyAdministration OralAntineoplastic AgentsDrug resistanceGastroenterologyYoung Adult03 medical and health sciencesHyperphosphatemia0302 clinical medicineRefractoryErdafitinibNeoplasmsQuinoxalinesInternal medicinemedicineHumansNeoplasmDosingAdverse effectProtein Kinase InhibitorsAgedNeoplasm StagingAged 80 and overbusiness.industryGenetic VariationMiddle AgedPrognosismedicine.diseaseReceptors Fibroblast Growth FactorTreatment Outcome030104 developmental biologyOncologyTolerabilityDrug Resistance Neoplasm030220 oncology & carcinogenesisRetreatmentPyrazolesFemalebusinessClinical Cancer Research
researchProduct